News
Johnson & Johnson (NYSE:JNJ) is included among the 10 Best Dividend Stocks to Buy for Retirement. Johnson & Johnson (NYSE:JNJ ...
Zacks.com on MSN5d
JNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results?JNJ edges out AZN following Q2 results with raised guidance, stronger estimate revisions and a more attractive valuation.
Johnson & Johnson (NYSE: JNJ) is one of the top cheap pharmaceutical stocks to buy now. On July 29, Johnson & Johnson ...
Yacktman Asset Management's Q2 2025 13F portfolio value dipped slightly to $7.44B. Click here to read more about the ...
Johnson & Johnson (NYSE: JNJ) is one of the top low volatility healthcare stocks to buy now. On July 17, Guggenheim raised ...
MarketBeat on MSN21d
JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is NowDetailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.
13d
AstraZeneca's gefurulimab showed clinical benefits and favorable safety in Phase 3 trial for adults with anti-AChR ...
Submission is supported by 24-week results from the Phase 3b APEX study in adults with active psoriatic arthritis treated ...
Zacks.com on MSN15d
JNJ Seeks FDA Approval for Oral Psoriasis Drug IcotrokinraJohnson & Johnson eyes FDA nod to icotrokinra after phase III studies show strong skin clearance and safety in plaque ...
Medpage Today on MSN1d
Trispecific Antibodies Emerging in Multiple MyelomaBuilding on bispecific antibodies, four of which have been approved by the FDA to treat relapsed/refractory multiple myeloma, ...
NDA for icotrokinra for the treatment of adults and adolescents 12 years of age and older with moderate to severe plaque psoriasis (PsO) submitted to U.S. FDA in July ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback